Infuse Bone Graft
-
Biologics
Medtronic Announces New Clinical Trial to Study Infuse Bone Graft in TLIF Spine Procedures
DUBLIN and CHICAGO, Sept. 26, 2019 (GLOBE NEWSWIRE) — Medtronic plc (NYSE:MDT) today announced U.S. FDA approval of a prospective, randomized…
Read More » -
Hospitals
Medtronic Announces FDA Approval of Infuse® Bone Graft for Three New Spine Surgery Indications
December 11, 2015 – Medtronic plc (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) approval of additional spine…
Read More »